Research Article
Published: 27 August, 2021 | Volume 5 - Issue 1 | Pages: 042-048
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in Wuhan, China, and caused coronavirus disease-19 (COVID-19), which is still a global pandemic. Dermatologic manifestations have increasingly been identified as significant extrapulmonary manifestations of COVID-19. The dermatologic manifestations associated with COVID-19 infection reported to date include maculopapular rash, vesicular lesions, urticaria-like lesions, and chilblain-like lesions. Knowledge of dermatologic manifestations of COVID-19 may be essential for early diagnosis and a better prognosis in COVID-19 patients. This review summarizes the current understanding of common COVID-19-associated dermatologic manifestations.
Read Full Article HTML DOI: 10.29328/journal.apb.1001015 Cite this Article Read Full Article PDF
Dermatologic; COVID-19; SARS-CoV-2; Maculopapular rash; Vesicular lesions; Urticaria-like lesions; Chilblain-like lesions
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."